National Multiple Sclerosis Society responds to AMA's revised opinion on Medical Marijuana

Last week the American Medical Association AMA made the historical recommendation to move medical marijuana off of Schedule 1. Multiple Scleroisis is one of the maladies for which the legalization of medical marijuana is currently advocated. As new data is revealed on the effects of marijuana as a treatment tool for MS the position of the society continues to evolve.

Today, 11/17/2009 the society issued an official statement regarding medical marijuana in light of the revised AMA policy.

“The National Multiple Sclerosis Society is currently supporting research looking at the potential impact of marijuana as a treatment tool for MS. Once that research is completed, we will be able to make a formal statement regarding the known risks and benefits for our constituents,” said Dr. John Richert, Executive Vice President, Research and Clinical Programs, National MS Society.